Thank you for standing by. This is the conference operator. Welcome to the Houlihan Lokey, Inc. fiscal first quarter 2022 earnings conference call. As a reminder, all participants are in listen-only mode, and the conference is being recorded. After the presentation, there'll be an opportunity to ask questions. To join the question queue, you may press star then one on your telephone keypad. Should you need assistance during the conference call, you may signal an operator by pressing star and 0. I would now like to turn the conference over to Christopher Crain, Houlihan Lokey's General Counsel. Please go ahead. Thank you, operator, and hello, everyone. By now, everyone should have access to our first quarter fiscal year 2022 earnings release, which can be found on the Houlihan Lokey website at www.hl.com in the investor relations section. Before we begin our formal remarks, we need to remind everyone that the discussion today will include forward-looking statements. These forward-looking statements, which are usually identified by use of words such as will, expect, anticipate, should, or other similar phrases, are not guarantees of future performance. These statements are subject to numerous risks and uncertainties that could cause actual results to differ materially from what we expect, and therefore, you should exercise caution when interpreting and relying on them. We refer all of you to our recent SEC filings for a more detailed discussion of the risks that could impact our future operating results and financial condition. We encourage investors to review our regulatory filings, including the Form 10-Q for the quarter ended June 30, 2021, when it is filed with the SEC. During today's call, we will discuss non-GAAP financial measures, which we believe can be useful in evaluating the company's financial performance. These measures should not be considered in isolation or as a substitute for our financial results prepared in accordance with GAAP. A reconciliation of these measures to the most directly comparable GAAP measures is available in our earnings release and our investor presentation on the hl.com website. Hosting the call today, we have Scott Beiser, Houlihan Lokey's Chief Executive Officer, and Lindsey Alley, Chief Financial Officer of the company. They will provide some opening remarks, and then we will open the call to questions. With that, I'll turn the call over to Scott. Thank you, Christopher. Welcome everyone to our first quarter fiscal 2022 earnings call. We are pleased to report another strong quarter. We achieved $373 million in first quarter revenues, up 77% from a year ago. This significant increase was compared to a relatively weak first quarter last year as a result of the pandemic. While our first quarter revenues were down from our exceptionally strong third and fourth fiscal 2021 quarters, $373 million in first quarter revenues were the best ever for what is usually our seasonally lowest quarter. All three of our business segments did very well. Corporate Finance and Financial and Valuation Advisory exhibited continued strength in a very robust M&A market environment, and Financial Restructuring delivered strong revenues and continued to maintain its significant market share during a challenging restructuring market environment. On the expense side, we reduced our compensation ratio from last year's level while maintaining historically low non-compensation expenses as we slowly return to in-person events and business travel. For the first fiscal quarter of 2022, we reported adjusted earnings of $1.19 per share, up 112% from last year. Our Corporate Finance business continued to benefit from a historically strong market, with all key metrics experiencing positive trends. New business activity remained at record levels. Our average transaction size and average fee per closed transaction were higher than previous years. Close rates were up with fewer transactions put on hold. Nearly every industry sector and geography experienced improved market environments, and our core product offerings of M&A, capital markets, and private funds advisory showed year-over-year growth. Our FVA business has done incredibly well over the last few years, growing its revenues at a five-year compounded average growth rate of just under 10%. All of our service lines within FVA performed above last year's levels, and the number of our clients, number of new clients, recurring clients, complexity of assignments, and average fees all increased. Our Financial Restructuring business continues to slow from the torrid pace it experienced last year. As previously discussed, Financial Restructuring is now operating at pre-pandemic activity levels, and we expect that levels of business to continue for the foreseeable future. However, an ever-increasing amount of corporate leverage, coupled with effects from the pandemic and continued disruption from technology, provides optimism for this business segment in the medium and long term. During the first quarter, we announced 16 newly promoted MDs, our largest class ever, and we hired five MDs, mostly in Corporate Finance. While competitive, we believe the hiring market remains strong, and we remain in active dialogue with a number of key prospective hires. Regarding our acquisition activity, we are excited to announce our commencement of a tender offer to acquire all of the outstanding equity of GCA Corporation for a total cash purchase price of approximately $591 million. The transaction is expected to be funded with cash on our balance sheet. GCA is a well-known global investment banking firm publicly traded on the Tokyo Stock Exchange. They have significant operations in the U.K. and Europe, the Asia Pacific region, and the U.S. Their primary focus is in technology and related sectors, but they also have expertise in a couple additional core industries complementary to our existing business. We plan to commence the tender offer for GCA shares shortly, and we anticipate closing the tender offer in the beginning of October. In the meantime, we have started planning for a smooth and successful integration of our two businesses. Within the press release issued yesterday announcing the transaction, we provided a link to a summary of GCA that gives a snapshot of the company and the transaction and explains our strategic rationale for wanting to commence the tender offer to make this acquisition. Let me highlight a few pro forma statistics from that presentation. Upon completion of the tender offer, Houlihan Lokey will have over 2,000 employees generating more than $1.8 billion in revenues on an annualized basis. We will have offices in 17 countries, and over 30% of our combined revenues will be outside the U.S. As a combined firm, revenues in our Technology, Media, and Telecom industry group will go from being underweighted relative to the industry size to becoming our largest and most global industry group. In many regards, this transaction is similar to the dozen or so transactions we have completed over the last decade. It's a business we know well, run by a management team that has a similar culture and business philosophy as we do. GCA and Houlihan Lokey share a number of important cultural traits, including a collaborative entrepreneurial approach, independent, thoughtful advice, and a relentless focus on its clients. While we believe this is an exciting transaction for our collective clients, employees, and shareholders, we also recognize the time and effort it will take to integrate these two businesses effectively. This is by far the largest transaction we've ever pursued, but we are up for the challenge and we are focused on a successful outcome. With that, I'll turn the call over to Lindsey. Thank you, Scott. Revenues in Corporate Finance were $210 million for the quarter, up 139% when compared to the same quarter last year. We closed 84 transactions this quarter, compared to 35 in the same period last year, and our average transaction fee on closed deals increased. As a reminder, our Corporate Finance business was negatively impacted by the pandemic in the same period last year. Financial Restructuring revenues were $99 million for the quarter, an 11% increase from last year's first quarter. We closed 24 transactions this quarter compared to 29 in the same period last year, and our average transaction fee on closed deals was significantly higher. Our restructuring activity has now returned to more normal pre-pandemic levels, and unless something changes, we expect to see solid but significantly lower restructuring revenues for the balance of fiscal 2022. In Financial and Valuation Advisory, revenues were $64 million for the quarter, an 85% increase from the same period last year. We had 820 fee events during the quarter compared to 512 in the same period last year, and we continue to see an increase in revenues per fee event. Turning to expenses, our adjusted compensation expenses were $229 million for the first quarter versus $132 million for the same period last year. Our only adjustment was for deferred payments related to certain acquisitions. Our adjusted compensation expense ratio was 61.5% for the quarter. Our adjusted non-compensation expenses were $32 million for the quarter versus $30 million for the same quarter last year, an increase of 6%. This resulted in an adjusted non-compensation expense ratio of 8.5% for the quarter versus 14.2% in the same period last year. This quarter, we adjusted out of our non-compensation expenses $1.1 million in acquisition-related amortization. We expect to see a significant increase in non-compensation expenses in fiscal 2022 as we begin to return to more normalized travel and operations, but we do not expect that to occur until the second half of the fiscal year. Our adjusted other income and expense decreased for the quarter to income of approximately $101,000 versus income of approximately $1.2 million in the same period last year. This was primarily a result of lower interest earned on our cash and investment balances. Our adjusted effective tax rate for the quarter was 26.7%, compared to 25.3% during the same quarter last year. As a reminder, a portion of the deferred stock that we issue as compensation to employees vests during the first quarter of each fiscal year, which was adjusted for in order to get to a more normalized effective tax rate for the quarter. Our long-term target for our adjusted effective tax rate is between 27% and 29%, although we expect our tax rate for fiscal 2022 to be closer to the lower end of the targeted range. Turning to the balance sheet and uses of cash. As of the quarter end, we had approximately $830 million of unrestricted cash and equivalents and investment securities. In our first quarter, we issued approximately $1.9 million net new shares to employees as part of their bonus compensation for fiscal 2021. We intend to offset this dilution through share repurchases throughout fiscal 2022. In our first quarter, we repurchased 1.4 million shares through either open market repurchases or repurchases meant to cover taxes on vesting shares at an average price of approximately $76.04 per share. Finally, moving to the acquisition of GCA. Given the length of the tender offer process, in the next quarter, we expect to be in a better position to answer questions that you will have regarding our integration strategy, the pro forma combined company financial profile, the accumulation and deployment of future cash, and the timing to achieve appropriate long-term targets. We believe this acquisition will be accretive to our shareholders at closing. We look forward to sharing with you our plan to drive shareholder value through the combination of these two businesses. With that, operator, we can open the line for questions. Thank you. We will now begin the question and answer session. To join the question queue, you may press star then one on your telephone keypad. You will hear a tone acknowledging your request. If you are using a speaker phone, please pick up your hands up before pressing any keys. To withdraw your questions, please press star then two. We will pause for a moment as callers as join the queue. Our first question comes from Ken Worthington of J.P. Morgan. Please go ahead. Hi, good morning. Thank you for taking my questions. I wanted to focus on the GCA deal, acknowledging you said that you'd get more into some of the strategic rationale next quarter. Talk to us a little bit about the growth of the company. Clearly, 2021 is great for M&A globally, and it looks like GCA is having a great start to 2021. It looks like revenue is down in 2019. What does the growth look like for this company over the last five years? Would you characterize it as a fast-growing company? It looks like it could have more stagnant growth, but I just don't have enough of a timeline yet to see that. First, talk to me about the growth. Morning, Ken. I think its performance and growth has been similar to not only our firm but other investment banking firms over the last couple of years. There's been some volatility, obviously, with the pandemic impact, especially in calendar 2020 for them. They're having a very good year in 2021, as is, I think, most everyone else in the marketplace. We think they're in a very good space, clearly in technology, which is one of the leading, if not the leading industry. They clearly have a lot of geographical diversity to continue to help their growth. Okay. How does this fit into the Houlihan vision? It seems to me the attraction is an attractive asset class, so technology diversifies the business by geography. Are there synergies here? The simple side would be cost synergies. I'm not sure there's anything there. Does it complement Restructuring or Financial Advisory anywhere? Are there synergies for your existing middle-market M&A business? Do you think you can do more cross-border deals with this company? Help me understand the synergies that you envision. Well, in many regards, we look at it very similar to the other dozen or so deals that we've done. Obviously, we mentioned this is a larger business in scale and scope. We've experienced almost every time whenever we've acquired a business that eventually we do get some revenue synergies. We're putting together two teams that have a different set of clients and experiences. We add to the geographical bench. We clearly strengthen the TMT industry. They don't have the restructuring business that we've got. They don't really have the same level of depth of the valuation group that we have. They really don't have the same level of the financial sponsor group that we have. All these things we believe combined would make both of the businesses stronger post-deal. Having said that, we know it takes time and it takes energy to get there, and that's kind of our expectations on the revenue synergies, and I'd say very similar to what we've experienced with our past deals. Great. Thank you very much. Thanks, Ken. Our next question comes from Steven Chubak of Wolfe Research. Please go ahead. Hi, good morning. Morning. Wanted to just start off with a question on the restructuring outlook. To your credit, I think you were pretty early in calling out some signs of the slowdown. The updates from your peers have been increasingly tepid. I just was curious, based on the prior guidance you guys had given of $300 million and $350 million being a reasonable range, is that still the level that we should be underwriting, just given the pace of activity in the near term, recognizing some of your optimism on the opportunity long term? Yeah, I think that's very specific guidance. I'm not sure we gave the $300-350 million, but we did say, look, we're at activity levels that were consistent with pre-pandemic. You can take a look at where we were the couple of years prior to entering into the pandemic, and that's not a terrible proxy. I think as we sit here today, I don't think any of our comments from previous calls have changed in terms of the restructuring market and our expectations for fiscal year 2022. Understood. Just for my follow-up, also relating to GCA, I was hoping to better unpack, recognizing that the transaction is financially compelling, but it does appear to increase your gearing to more cyclical revenue streams. I know, talking to many investors, I think a big part of their optimism and bullishness on the prospects for Houlihan is that balanced revenue mix. Was hoping you can give us some context around how your thinking is evolving around the increased gearing, it appears, to Corporate Finance. It sounded like, Scott, you alluded to maybe them being a little bit less indexed to sponsor activity, although it does feel like they're pretty active there as well. Any context you can give around the pro forma revenue mix and how it changes, at least your relative cyclicality, would be really helpful. Yes. Steven, just to clarify on the financial sponsors comment, they do a lot of work with financial sponsors. They just don't have as many dedicated financial sponsor coverage officers as we do. We clearly look at this as being very similar to what Houlihan Lokey does in Corporate Finance. It's predominantly M&A, more sell side than buy side. They also have capital markets activities. They tend to work in both the middle market and upper middle market space. They add additional industry sub-sector expertise. While historically they've not been focused on restructuring or valuation like our firm does, we think that is an opportunity, just as we have those bankers and those capabilities. We think it will enhance the overall growth of the business. Do recognize your comment. Yes, we are adding more, I'll call it Corporate Finance activity, statistically versus adding incremental restructuring or valuation revenues. I do think it's important to note, when you go as deep as we would go with this acquisition in an industry space like technology, that benefits the entire firm. That benefits our restructuring folks, enables them to win technology transactions because of industry expertise that we might not have been able to do previously. It benefits our FVA business in terms of credibility with sophisticated clients. It's not like yes, their revenues are predominantly Corporate Finance, but one of the reasons we do transactions like this is so that revenue mix, given the industry depth that we're acquiring here, will improve for GCA and for Houlihan Lokey on a go-forward basis. That's great color. Thank you both for taking my questions. Thanks, Steven. Our next question comes from Michael Brown of KBW. Please go ahead. Great. Thanks for taking my questions. If I could start on GCA. I guess first I wanted to ask a little bit about the structure of the transaction given it's a tender. I wanted to ask, is there any retention component to the deal? Obviously, that's kind of key to success in deals in this space, and so just curious if that's contemplated here or if that maybe comes down the road. Yes, we do have a retention pool contemplated. The exact details are not completely defined at this point. Okay, great. Obviously, M&A activity in Europe and in Asia have lagged the U.S. and it's been steadily improving in Europe and we're seeing that rebound there. Asia's kind of continuing to lag, but there's clearly some pent-up demand there. Can you just speak a little bit more to your outlook for each of those regions and your expectations there as you look forward? I'd say we have a very similar view for probably the last, I don't know if it's three years or 10 years, which is there's a lot of growth potential in Europe, in Asia. Having said that, the U.S. has been the star of business recovery growth, et cetera, for quite some time. We like to be able to have access to do work in really all of those key geographies because we think there's opportunities not only in the United States, but clearly in Europe, clearly in Asia. There's other places in the globe that we're still just touching on and would hope over time to eventually grow into some additional geographies. Okay, great. I'll leave it there, Scott. Thanks. Thanks. Thanks, Mike. Our next question comes from Richard Ramsden of Goldman Sachs. Please go ahead. Hey, guys. Just on GCA, could you just spend a few minutes talking about the due diligence process and what that looked like? Obviously, given the travel restrictions and given the fact that this is, as you said, one of the bigger deals that you have done. We've known some of the key people in the company for many years, so that's helped. We've been dialoguing with them for a decent amount of time. As you said, we've not been able to do the typical in-person diligence that you would like. We've done a lot of Zoom and telephonic diligence, and much like all of us in the investment banking business, we've all figured out how to do deals for our clients not in person and feel the same way here. We sure would prefer to have always been able to do more things in person, but feel we got accomplished what we needed on both sides of the equation to get more comfortable with each other. Okay, great. Then just briefly on the FVA business, it continues to do very well. It's obviously an important driver of revenue growth for you. I know you touched on this in some of your upfront remarks, but can you just help us think through how much of this increase is recurring mandates that we should expect in future years? To what extent do you think that this is a base from which you can grow, just given the nature of the business that you or the new business that you're getting in FVA? First, I'd say we're very optimistic overall about the growth profile of what's happening in FVA. When you ask the question about repeat clients, I'd look at it really two ways. Number of clients or potential revenues truly under contract that you can almost totally identify year by year, is somewhere probably in 1/3 to 1/2 of that business. If you really look at almost any of our clients, you could argue it's a much, much higher number from a repeat standpoint, meaning we do a lot of work for the various financial sponsors. We do a lot of work for a lot of companies. We may not know what that exact task is three months from now or two years from now, but a lot of the work that we do is I would put in the repeat category. It's both growing by doing more work for existing clients, by adding additional clients, as well as adding additional services over the last handful of years. Okay. That's very helpful. Thanks a lot. Thanks, Richard. Our next question comes from Brennan Hawken of UBS. Please go ahead. Good morning, Scott and Lindsey. Thanks for taking my question. Hi. On GCA, understanding that you can't speak to the pro forma combined entity, and we'll get more of that on the next quarterly call. When we look at the profit margins, the operating margins of this business, they look like they run about half of Houlihan's, low double- digit, maybe to teens. When you took a look at this company and you did your due diligence, is there something structural to that? Is that the scaled profitability of this business, or is the idea that when you fold this company into Houlihan, there's enough overlapping duplication of whatever overhead and whatnot that you can deliver scale benefit? Should we think about this as likely just reducing the longer run operating margin at Houlihan? Brennan, a couple things I'd say. One, most, if not maybe all of the previous acquisitions we've done, those companies have had lower margins than Houlihan Lokey. This is not an unusual fact pattern for us. Two, much like the size that we were prior to going public, we had much lower margins than we're currently performing. I do think there's a scale and size issue that occurs. Three, it's how they've historically operated, and we do think while it will take some time, but effectively by adding, once again, the incremental bench strength that we have combined with theirs, we'll be able to find more clients, do more work for clients, get higher fees, increase close rates. None of what I've just said is unusual for this particular transaction. I'd say that's similar to what we've experienced with most of our previous transactions. Okay. Thanks for that. When you think about geographic diversity, it's one of the things that you mentioned as the benefits around this deal. If I could push back on that a bit. When you look across this business, firms that are geographically diverse have grown at a pretty substantially slower pace. Houlihan previously had a very unique proposition where you were focused on middle markets. The three business units all came together really well, and there was a clear, synergy is probably the wrong word, but clear benefits from being in these different businesses. Now when you introduce a lot of European and APAC revenues, much more Corporate Finance-oriented, why is that necessarily going to continue to feed into this virtuous cycle that you have between your businesses? Should we think that while the revenue outlook for 2021 is good versus last year, when you go back and look at some of the history, the outlook for 2021 revenues is basically just going to get them back to where they were in 2018. It seems as though the growth profile of the business that you're buying is lower. That's what I'm hearing from a lot of investors this morning. Why is that wrong? Why do you think that this is a more attractive asset where that diversity can actually be a tailwind? I think you asked a couple questions there, Brennan. Let me take on the geographical growth. We have said to ourselves, to our investors, over many years, that we've wanted to increase our non-U.S. presence. We recognize in finance is very much a global business, and we've continually deployed, I would say, money, time, and effort in growing our non-U.S. business. That's the good news. The fact pattern is the U.S. has just continued to grow as well, and we've been at roughly probably an 80/20 mix for quite some time. We believe this will increase our non-U.S. positioning. Not so much that it makes the U.S. a statistical much smaller place, but actually we think gets us more consistent with really where activity is across the globe. As we do more work and as we do work on larger deals, it's just more important to have some access in different parts of the globe. We think a deal like this, and much like acquisitions we made in the past, has been very good opportunities for us. In terms of the growth profile, once again, we've looked at the space that they're in. We've looked at the space that we're in. We think it fills some holes. We think they will, with ourselves collectively, continue to be able to grow over the years. Like I said, we think they're doing well. We think the markets are doing well. We think we can continue to do well on ourselves. Caution, everybody, we do know when we do make acquisitions, it does take some time for all of those potential synergies to kick in. I think a couple other things just to add, Brennan. We're not growing overseas for the sake of growing overseas. We think we have built in all three of our product lines, a phenomenal platform here in the United States. Restructuring, I think in particular, has shown an ability to take that overseas incredibly effectively. We think we can do the exact same thing with Corporate Finance. We have kind of a long-term view of how we're going to get there, and this is one step. I think it's not how Europe is doing relative to the U.S. today. It is a kind of long-term vision on taking that Corporate Finance platform to Europe, to Asia, and just globally. It's not just for the sake of growing, it's because our clients are insisting on it. Okay. Thanks for the color. Once again, if you have a question, please press star then one. Our next question comes from Devin Ryan of JMP Securities. Please go ahead. Okay, great. Thanks. Good morning, everyone. Just another one here on GCA, but kind of a bigger picture just on kind of the M&A strategy for Houlihan. Clearly you guys have been incredibly active on the M&A front. This is your largest deal and you had alluded to several large deals a year ago or so. I'm curious, was this included in that contemplation? Does this put you guys out of the market just because it's a larger transaction, integration's probably a little bit different here than some of the other deals, or do you feel like you can continue to do deals over the intermediate term and are there actually other large deals kind of that are being contemplated? We're still talking to other companies. Still expect to be pursuing potential future acquisitions. I think it's probably unrealistic over the near term to do a similar size type of acquisition as GCA. Most of our historical deals have been much, much smaller, and if the right fact patterns present itself over the next quarter, next year, et cetera, we'll continue to pursue transactions. Okay, great. Just a follow-up on middle markets M&A broadly. If you can, Scott, talk a little about the competitive dynamics. Many firms throughout the last few quarters on earnings calls, large bulge brackets and independent firms have been talk efforts in building out their capabilities, both in the middle markets but more broadly with sponsors. You guys have a leading position there and have been doing it longer and deeper than many firms. I'm just curious how the competitive dynamics are shifting and as more firms come in and try to take share. I don't think the competitive landscape today is any greater than it was a year or two or three years ago. The market is more robust, so there's more activity and more deals for everybody to do. But I would say in terms of who do we see from competition, who do we compete against, what do we have to do to win, it's not dramatically different, at least in the space and areas that we focus on from where it's been in the last year or two. Okay, great. Thanks very much. All right, Devin. This concludes the question and answer session. I would like to turn the conference back over to Scott Beiser for any closing remarks. Well, I want to thank you all for participating in our first quarter fiscal year 2022 earnings call. We look forward to updating everyone on our progress when we discuss our second quarter results for fiscal year 2022 this coming fall. This concludes today's conference call. You may disconnect your lines. Thank you for participating and have a pleasant day.